FRANKFURT – An oral drug combination by Swiss pharmaceuticals company Novartis showed promise in treating a subgroup of patients suffering from a common childhood brain cancer in a trial. In…
DSP-0390, an investigational new agent developed by Cambridge, Massachusetts-based Sumitomo Dainippon Pharma Oncology, is an inhibitor of emopamil-binding protein (EBP), a molecule in cholesterol biosynthesis. DSP-0390 has not been approved…
The New York Police City Department arrested a man for allegedly attacking a woman with a hammer in the Subway Thursday evening. The suspect could be seen following the victim…
TRENTON, NJ – More college-age residents are leaving New Jersey than any other state, and the 10th District lawmakers say that is a powerful indicator of bigger problems in Democrat-controlled…